Cargando…
Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
Autores principales: | Li, Tian, Sun, Xiangzhou, Xu, Kewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912637/ https://www.ncbi.nlm.nih.gov/pubmed/36759851 http://dx.doi.org/10.1186/s13578-023-00976-x |
Ejemplares similares
-
The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
por: Li, Tian, et al.
Publicado: (2018) -
miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction]
Publicado: (2021) -
Retraction Note: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma
por: Mirghasemi, Alireza, et al.
Publicado: (2016) -
Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2019) -
Retraction Note to: Downregulation of miR-483-5p decreases hypoxia-induced injury in human cardiomyocytes by targeting MAPK3
por: Hao, Yan, et al.
Publicado: (2021)